FMR LLC - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 56 filers reported holding ENTRADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.1%.

Quarter-by-quarter ownership
FMR LLC ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,197,433
+4.4%
582,116
+0.0%
0.00%0.0%
Q2 2023$8,810,526
-42.8%
581,937
-45.2%
0.00%0.0%
Q1 2023$15,410,832
+126.2%
1,062,816
+110.9%
0.00%0.0%
Q4 2022$6,812,877
-14.2%
503,911
+0.0%
0.00%0.0%
Q3 2022$7,942,000
-31.0%
503,907
-46.7%
0.00%0.0%
Q2 2022$11,509,000
+39.8%
944,908
+7.8%
0.00%0.0%
Q1 2022$8,233,000
+68.3%
876,794
+206.8%
0.00%
Q4 2021$4,893,000285,8000.00%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,425,784$64,173,86826.74%
5AM Venture Management, LLC 4,408,379$63,921,49616.35%
72 Investment Holdings, LLC 509,023$7,380,8333.50%
StepStone Group LP 761,277$11,038,5172.05%
TCG Crossover Management, LLC 584,955$8,481,8481.65%
Redmile Group, LLC 1,831,608$26,558,3161.15%
Nan Fung Group Holdings Ltd 73,582$1,066,9390.73%
Baker Brothers Advisors 4,865,819$70,554,3760.38%
CHI Advisors LLC 56,374$817,4230.22%
MOORE CAPITAL MANAGEMENT, LP 105,000$1,522,5000.03%
View complete list of ENTRADA THERAPEUTICS INC shareholders